| Old Articles: <Older 48271-48280 Newer> |
 |
The Motley Fool April 27, 2011 Frank Vinluan |
Inspire's Pink Eye Drug AzaSite Draws Generic Challenge This sought-after drug could soon be facing generic competition.  |
The Motley Fool April 27, 2011 |
5 Smart Stocks for Retirees Let these stocks protect your portfolio.  |
The Motley Fool April 27, 2011 Arundhati Parmar |
Medtronic and Eli Lilly Join Hands to Combat Parkinson's Disease The partnership aims to research and develop a new approach to treating the debilitating disease.  |
The Motley Fool April 26, 2011 Anders Bylund |
Apple's Location Scandal: Nothing But Hot Air There are bigger issues to worry about, like the baggage retrieval system they've got at Heathrow.  |
The Motley Fool April 26, 2011 Anders Bylund |
Larry Picks His Top Gun Ellison needed to take Catz to the big dance or lose her forever.  |
The Motley Fool April 26, 2011 Chris Hill |
Why Netflix Has Us Seeing Red Listen up! We have things to say about Netflix, Ford, and Coca Cola.  |
The Motley Fool April 26, 2011 Brian Orelli |
There Is Only Downside in Consensus Hepatitis C advisory panels will almost certainly recommend approval. Almost.  |
The Motley Fool April 26, 2011 David Lee Smith |
BP's Cheap -- and Worth Your Attention With studies placing Macondo blame on its contractors, BP merits attention.  |
The Motley Fool April 26, 2011 Anders Bylund |
Can Maxim Cheat the Tax Man? Nothing is sure but death, taxes, and the desire to cheat 'em.  |
The Motley Fool April 26, 2011 Travis Hoium |
SunShot Taking Its Best Shot at $1 Solar Power The U.S. government's SunShot Initiative may help solar manufacturers where they need it most.  |
| <Older 48271-48280 Newer> Return to current articles. |